The effect of intrathecally administered imiloxan and WB4101: possible role of α2-adrenoceptor subtypes in the spinal cord
- 4 September 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 219 (3-4) , 465-468
- https://doi.org/10.1016/0014-2999(92)90490-u
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacology of Intrathecal Adrenergic AgonistsAnesthesiology, 1990
- Assessment of imiloxan as a selective α2B‐adrenoceptor antagonistBritish Journal of Pharmacology, 1990
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988
- Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitroEuropean Journal of Pharmacology, 1987
- Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processingPharmacology Biochemistry and Behavior, 1985
- Receptor interactions of imidazolines influence of ionization constant on the diffusion of clonidine and a series of structurally related imidazolidines into and out of the central nervous systemEuropean Journal of Pharmacology, 1982
- Antagonist/agonist-preferring α-adrenoceptors or ?European Journal of Pharmacology, 1980